Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations

ANI Pharmaceuticals Inc to acquire Novitium Pharma LLC

Announced Mar 9, 2021 · Closed Nov 26, 2021 · Private target

Deal value$164M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationCash and stock

Transaction

Acquirer
ANI Pharmaceuticals Inc (ANIP)
Target
Novitium Pharma LLC
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Closed Nov 26, 2021

Deal protections

Not disclosed for private-company acquisitions.

Advisors

To the acquirer
Truist Securities, Houlihan Lokey
To the target
Leerink Partners

Classification

Sector
Healthcare
Buyer's industry
Pharmaceutical Preparations
Sources
  • 8-K (EX-99) · Mar 9, 2021
  • 8-K · Mar 9, 2021
  • 8-K (EX-99.1) · Nov 26, 2021

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.